← Leaderboards
Michael Emerman
Fred Hutchinson Cancer Research Center
$21,222,986
Attributed
$21,222,986
Total exposure
9
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.9M · FY2005–24$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$21,222,986 · 9
By mechanism
R01$9,200,254 · 4
R37$4,596,445 · 1
DP1$4,400,000 · 1
P50$2,464,825 · 2
R56$561,462 · 1
Top collaborators
No co-investigators on record.
Most similar at Fred Hutchinson Cancer Research Center
Same institution · by research overlap
- Molly Ohainle$2,161,250
- Peter Kiem Hans$1,130,122
Others in their field
Top investigators on “Virus”
- David Heimbrook · Leidos Biomedical Research, Inc.$512,873,478
- Lawrence Corey · Fred Hutchinson Cancer Center$392,679,667
- Barton F Haynes · Duke University$328,711,626
- Dennis R. Burton · Scripps Research Institute$276,624,892
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$274,342,142
- Richard Webby · St. Jude Children'S Research Hospital$265,067,789
Research focus
VirusCellsGenesViralAntiviral AgentsSubfamily LentivirinaeProteinsHiv-1InfectionAffectEvolutionVirus ReplicationGrantTransmission ProcessBiologyVirus DiseasesMutantMutationCell CommunicationGenomeInnovationPandemic DiseaseGenetic PolymorphismRecording Of Previous Events
Grant awards (45)
HIV-CRISPR: A novel approach to the comprehensive discovery of HIV latency factors$880,000
DP1 · FY2024 · DA · contact PI
HIV-CRISPR: A novel approach to the comprehensive discovery of HIV latency factors$880,000
DP1 · FY2023 · DA · contact PI
HIV-CRISPR: A novel approach to the comprehensive discovery of HIV latency factors$880,000
DP1 · FY2022 · DA · contact PI
HIV-CRISPR: A novel approach to the comprehensive discovery of HIV latency factors$880,000
DP1 · FY2021 · DA · contact PI
Characterization of Super Restriction Factors and Prediction of Host-HIV Interfaces$489,170
P50 · FY2021 · AI · contact PI
HIV-CRISPR: A novel approach to the comprehensive discovery of HIV latency factors$880,000
DP1 · FY2020 · DA · contact PI
HIV Host-Cell Interactions$523,059
R01 · FY2020 · AI · contact PI
Characterization of Super Restriction Factors and Prediction of Host-HIV Interfaces$492,324
P50 · FY2020 · AI · contact PI
HIV Host-Cell Interactions$523,059
R01 · FY2019 · AI · contact PI
Characterization of Super Restriction Factors and Prediction of Host-HIV Interfaces$492,351
P50 · FY2019 · AI · contact PI
HIV Host-Cell Interactions$523,059
R01 · FY2018 · AI · contact PI
Characterization of Super Restriction Factors and Prediction of Host-HIV Interfaces$487,942
P50 · FY2018 · GM · contact PI
Characterization of Super Restriction Factors and Prediction of Host-HIV Interfaces$503,038
P50 · FY2017 · GM · contact PI
HIV Host-Cell Interactions$282,082
R01 · FY2017 · AI · contact PI
HIV Host-Cell Interactions$561,462
R56 · FY2016 · AI · contact PI
The Evolution of Vpr/Vpx Function in Primate Lentiviruses$321,434
R01 · FY2016 · GM · contact PI
HIV Host-Cell Interactions$737,398
R01 · FY2015 · AI · contact PI
The Evolution of Vpr/Vpx Function in Primate Lentiviruses$322,823
R01 · FY2015 · GM · contact PI
HIV Host-Cell Interactions$604,414
R01 · FY2014 · AI · contact PI
The Evolution of Vpr/Vpx Function in Primate Lentiviruses$324,063
R01 · FY2014 · GM · contact PI
HIV Host-Cell Interactions$133,957
R01 · FY2014 · AI · contact PI
HIV Host-Cell Interactions$569,046
R01 · FY2013 · AI · contact PI
The Evolution of Vpr/Vpx Function in Primate Lentiviruses$325,171
R01 · FY2013 · GM · contact PI
HIV Host-Cell Interactions$539,529
R01 · FY2012 · AI · contact PI
HIV Host-Cell Interactions$541,280
R01 · FY2011 · AI · contact PI
HIV Host-Cell Interactions$509,259
R37 · FY2010 · AI · contact PI
HIV Infection of Non-Dividing Cells$294,027
R01 · FY2010 · AI · contact PI
HIV Host-Cell Interactions$499,655
R37 · FY2009 · AI · contact PI
HIV Infection of Non-Dividing Cells$296,998
R01 · FY2009 · AI · contact PI
HIV Infection of Non-Dividing Cells$206,581
R01 · FY2009 · AI · contact PI
HIV Host-Cell Interactions$485,337
R37 · FY2008 · AI · contact PI
HIV Infection of Non-Dividing Cells$296,998
R01 · FY2008 · AI · contact PI
HIV Host-Cell Interactions$480,567
R37 · FY2007 · AI · contact PI
HIV Infection of Non-Dividing Cells$302,750
R01 · FY2007 · AI · contact PI
HIV Host-Cell Interactions$480,752
R37 · FY2006 · AI · contact PI
VPR AND HIV INFECTION$432,500
R37 · FY2005 · AI
Accessory roles of Tat in HIV-1 replication$297,558
R01 · FY2005 · AI
VPR AND HIV INFECTION$432,500
R37 · FY2004 · AI
Accessory roles of Tat in HIV-1 replication$297,758
R01 · FY2004 · AI
VPR AND HIV INFECTION$432,500
R37 · FY2003 · AI
Accessory roles of Tat in HIV-1 replication$297,950
R01 · FY2003 · AI
VPR AND HIV INFECTION$432,500
R37 · FY2002 · AI
Accessory roles of Tat in HIV-1 replication$298,135
R01 · FY2002 · AI
VPR AND HIV INFECTION$410,875
R37 · FY2001 · AI
VPR AND HIV INFECTION$341,125
R01 · FY2000 · AI